Acura Stock Soars (ACUR)

NEW YORK (TheStreet) -- Shares of Acura Pharmaceuticals (Nasdaq:ACUR) have taken a tremendous swing upward. The stock is trading at $3.57 as of 2:01 p.m. ET, 20.6% above Thursday's closing price of $2.96. Volume is at 421,729, 4.4 times the daily average of 94,900.

Acura has a market cap of $132.8 million and is part of the health care sector and drugs industry. Shares are down 10.6% year to date as of the close of trading on Thursday.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies. The company has a P/E ratio of 19.5, above the average drugs industry P/E ratio of 16.3 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Acura as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full Acura Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.

For more information on Acura Pharmaceuticals Inc. click any of the following:

• Acura Pharmaceuticals Inc. Stock Price

• Acura Pharmaceuticals Inc. Analyst Ratings

• Acura Pharmaceuticals Inc. Key Stats & Profile

• Acura Pharmaceuticals Inc. Earnings

• Acura Pharmaceuticals Inc. Ratio Comparison

• Acura Pharmaceuticals Inc. Growth Rates

• Acura Pharmaceuticals Inc. Balance Sheet

• Acura Pharmaceuticals Inc. Cash Flow

• Acura Pharmaceuticals Inc. Income Statement